Combinostics

Tietoa

Combinostics develops AI-powered clinical decision support tools for neurological disorders through their cloud-based cNeuro platform, offering automated brain MRI quantification, differential diagnosis, and PET/SPECT image analysis. The platform targets Alzheimer's, frontotemporal dementia, vascular dementia, and multiple sclerosis, with regulatory approvals in the US and Europe.